Dyne Therapeutics Inc (DYN)
24.84
+1.14
(+4.83%)
USD |
NASDAQ |
Apr 26, 14:14
Dyne Therapeutics Cash and Short Term Investments (Quarterly): 123.10M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 123.10M |
| September 30, 2023 | 157.82M |
| June 30, 2023 | 207.73M |
| March 31, 2023 | 238.21M |
| December 31, 2022 | 256.01M |
| September 30, 2022 | 248.14M |
| June 30, 2022 | 291.84M |
| March 31, 2022 | 323.15M |
| Date | Value |
|---|---|
| December 31, 2021 | 376.57M |
| September 30, 2021 | 407.52M |
| June 30, 2021 | 435.59M |
| March 31, 2021 | 483.08M |
| December 31, 2020 | 345.31M |
| September 30, 2020 | 379.61M |
| June 30, 2020 | 144.87M |
| December 31, 2019 | 14.63M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
14.63M
Minimum
Dec 2019
483.08M
Maximum
Mar 2021
277.08M
Average
273.92M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Rocket Pharmaceuticals Inc | 373.18M |
| Solid Biosciences Inc | 123.64M |
| Avidity Biosciences Inc | 595.35M |
| Sana Biotechnology Inc | 205.20M |
| Tenaya Therapeutics Inc | 104.64M |